Enveric Biosciences Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Direxion Daily Semiconductor Bull 3X Shares trades at $140.07. The key difference: Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SOXL | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $300.77 |
52-Week Low | $1.28 | $23.99 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
SOXL, the Direxion Daily Semiconductor Bull 3X Shares ETF, is trading at $140.00, down 20.75% over 24 hours amid a broader semiconductor sell-off. Technical indicators are bearish, with moving averages signaling strong selling pressure and oscillators neutral. Recent news highlights volatility driven by SK Hynix's U.S. listing and competitive pressures in the memory chip sector. The fund's leveraged structure amplifies losses during market downturns, as seen in recent sharp declines.
The outlook for SOXL remains highly volatile, with near-term risks outweighing opportunities. Leveraged decay and sector-specific headwinds, including increased DRAM production and AI-driven market shifts, pose significant challenges. Investors should be cautious, as the fund is best suited for short-term tactical plays rather than long-term holdings, given its sensitivity to semiconductor stock fluctuations and inherent volatility decay.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →